Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature

PHASE4RecruitingINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Migraine

Interventions

DRUG

Flunarizine

The flunarizine will be given per clinical routine

OTHER

healthy control

no intervention for healthy control

Trial Locations (1)

RECRUITING

Headache Center, Teipei Veterans General Hospital, Taipei

All Listed Sponsors

lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV